AI assistant
Sight Sciences, Inc. — Director's Dealing 2021
Jul 15, 2021
33763_dirs_2021-07-14_ce39c250-4a09-456d-ab97-e8e0dba13f0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2021-07-14
Reporting Person: Selnick Jesse (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.35 | 2028-02-27 | Common Stock (120000) | Direct | |
| Stock Option (Right to Buy) | $0.62 | 2029-04-16 | Common Stock (40000) | Direct | |
| Stock Option (Right to Buy) | $10.96 | 2031-05-24 | Common Stock (300000) | Direct | |
| Series A Redeemable Convertible Preferred Stock | $ | Common Stock (1739130) | Indirect | ||
| Series B Redeemable Convertible Preferred Stock | $ | Common Stock (236988) | Indirect | ||
| Series C Redeemable Convertible Preferred Stock | $ | Common Stock (243450) | Indirect |
Footnotes
F1: The option vests and becomes exercisable as to 25% of the underlying securities on January 23, 2019 and in 36 equal monthly installments thereafter.
F2: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on April 18, 2019.
F3: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on June 24, 2021.
F4: The preferred stock is convertible into common stock on a 2 for 1 basis and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F5: These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels.